Metacrine OverviewMetacrine Research & Development
Research & Development expenses for MTCR.
Quarterly R&D Expenses
$1.32M
↓ 90.61% YoY
As of Sep 30, 2022
Annual R&D Expenses (TTM)
$19.49M
↓ 54.8% YoY
Trailing 12 months ending Sep 30, 2022
Metacrine OverviewResearch & Development expenses for MTCR.
As of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022